Valganciclovir for the prophylaxis of cytomegalovirus disease in pediatric liver transplant recipients

被引：19

作者：

Clark, BS

Chang, IF

Karpen, SJ

Herrera, L

Scott, JD

Bristow, LJ

Quirós-Tejeira, RE

Goss, JA

机构：

[1] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA

[2] Baylor Coll Med, Dept Gastroenterol, Houston, TX 77030 USA

[3] Baylor Coll Med, Dept Hepatol, Houston, TX 77030 USA

[4] Baylor Coll Med, Texas Childrens Liver Ctr, Nutr Unit, Houston, TX 77030 USA

[5] Baylor Coll Med, Texas Childrens Liver Ctr, Dept Surg, Houston, TX 77030 USA

来源：

TRANSPLANTATION | 2004年 / 77卷 / 09期

关键词：

D O I：

10.1097/01.TP.0000123081.81022.33

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1480 / 1480

页数：1

共 4 条

[1] Pharmacokinetics of valganciclovir and ganciclovir following multiple oral dosages of valganciclovir in HIV- and CMV-seropositive volunteers [J].

Brown, F ;

Banken, L ;

Saywell, K ;

Arum, I .

CLINICAL PHARMACOKINETICS, 1999, 37 (02) :167-176

[2] Single-dose pharmacokinetics of valganciclovir in HIV- and CMV-seropositive subjects [J].

Jung, D ;

Dorr, A .

JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 39 (08) :800-804

[3] Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients [J].

Pescovitz, MD ;

Rabkin, J ;

Merion, RM ;

Paya, CV ;

Pirsch, J ;

Freeman, RB ;

O'Grady, J ;

Robinson, C ;

To, Z ;

Wren, K ;

Banken, L ;

Buhles, W ;

Brown, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) :2811-2815

[4] Infectious complications of solid organ transplantations [J].

Simon, DM ;

Levin, S .

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2001, 15 (02) :521-+

← 1 →